To describe the proportion of individuals 5-49 years of age who shed vaccine strain viruses. 28 days after vaccination [clinicaltrials_resource:b48acfd42d6e8776058f150c96e781e6]

To describe the proportion of individuals 5-49 years of age who shed vaccine strain viruses. 28 days after vaccination [clinicaltrials_resource:b48acfd42d6e8776058f150c96e781e6]

FluMist
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:b48acfd42d6e8776058f150c96e781e6
Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age [clinicaltrials:NCT00192140]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

To describe the proportion of individuals 5-49 years of age who shed vaccine strain viruses. 28 days after vaccination [clinicaltrials_resource:b48acfd42d6e8776058f150c96e781e6]

FluMist
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:b48acfd42d6e8776058f150c96e781e6
Bio2RDF identifier
b48acfd42d6e8776058f150c96e781e6
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b48acfd42d6e8776058f150c96e781e6
measure [clinicaltrials_vocabulary:measure]
To describe the proportion of ...... o shed vaccine strain viruses.
time frame [clinicaltrials_vocabulary:time-frame]
description
identifier
clinicaltrials_resource:b48acfd42d6e8776058f150c96e781e6
title
To describe the proportion of ...... ses. 28 days after vaccination
@en
inDataset
type
label
To describe the proportion of ...... acfd42d6e8776058f150c96e781e6]
@en